hrp 102 has been researched along with fibrinogen in 2 studies
| Studies (hrp 102) | Trials (hrp 102) | Recent Studies (post-2010) (hrp 102) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 33 | 19 | 8 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulent Tiras, M; Darney, PD; Fener, N; Guner, H; Noyan, V; Yildirim, M | 1 |
2 trial(s) available for hrp 102 and fibrinogen
| Article | Year |
|---|---|
Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters.
Topics: Adolescent; Adult; Bilirubin; Blood Coagulation; Cholesterol; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Fibrinogen; Humans; Injections; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menstruation; Norethindrone; Partial Thromboplastin Time; Prothrombin Time; Serum Albumin; Triglycerides | 2001 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |